R&D

News

Sanofi's multiple myeloma drug approved in EU

Sanofi’s new multiple myeloma drug Sarclisa (isatuximab) has been approved in the EU for relapsed/refractory disease, taking on Johnson & Johnson’s well-established blockbuster Darzalex

News

FDA extends review of Novartis' MS drug ofatumumab

The FDA has extended its review of Novartis’ potential multiple sclerosis drug ofatumumab, pushing back a decision on the repurposed cancer drug until September this year.

Views & Analysis

Coronavirus news roundup - 29/05/2020

A series of vaccines and drugs are being fast-tracked through the big pharma pipeline as part of a coordinated global response to the

News

GSK to produce a billion doses of COVID-19 vaccine booster b...

GlaxoSmithKline is to scale up production of its COVID-19 vaccine booster to a billion doses by 2021 to support development of several potential jabs.

News

UK okays early access to Gilead's remdesivir in seriously il...

The UK’s drugs regulator has said that there is enough evidence to support the use of Gilead’s COVID-19 drug remdesivir under its Early Access to Medicines Scheme (EAMS).

News